Tests a blood pressure support tool to help protect thinking skills
Tests a decision support tool and team care for older adults with high blood pressure.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- Preventing Cognitive Decline by Reducing BP Target Trial
- Status
- Recruiting
- People taking part
- 4,000 people, planned
- Started
- 11 Jul 2022
- Planned end
- 31 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Clinical Support Decision Tool
- Record updated
- 3 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 70 or older who have had high blood pressure in the past 24 months. It tests whether special blood pressure care lowers the chance of memory problems.
- Age
- 70 years or older
- Sex
- All sexes can join.
- Disease stage
- High blood pressure: at least 1 reading of SBP >= 130 or DBP >=80 in the 24 months before joining.
- Earlier treatment
- A clinic visit with a primary care provider in the last 24 months.
Main reasons for not taking part
- Blood pressure consistently below 130/80 mmHg
- Dementia, Alzheimer's disease or significant neurological disease
- Major and unstable heart disease
- Chronic kidney disease stage 5 or ESKD
- Chemotherapy
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- High BP defined as at least 1 BP readings of SBP >= 130 or DBP >=80 during the 24 months prior to enrollment
- Clinic visit with primary care provider within the last 24 months
- Ability to write and speak English or Spanish
- 70 years of age or older
- Ability to understand and willingness to provide informed consent
- Owns a smartphone
Who cannot take part
- Chemotherapy
- Presence of dementia, Alzheimer's disease, or significant neurological disease
- Major and unstable heart disease (e.g., acute heart failure (systolic or diastolic), acute on chronic heart failure (systolic or diastolic), acute coronary syndrome or cardiac arrest, liver or renal transplantation
- Chronic kidney disease stage 5 or ESKD
- Any conditions judged by the medical providers to contraindicate participation due to risk to patient safety or lack of adherence
- Under 70 years of age
- Blood pressure consistently <130/80 mmHg
- Inability to write or speak English or Spanish
- Expected life expectancy under a year
Where in United States
- UT Southwestern Medical CenterDallas, United StatesContact: Miguel Vazquez, MDTaking people
About the trial
What the trial wants to find out
The PCOT study is a multi-site randomized trial of patients 70 years or older with high BP. The main goal of the study Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) is to conduct a large pragmatic clinical trial (PCT) to test the hypothesis that patients who receive care with a combination of clinical decision support (CDS) and team-based care delivered in primary care practices will have better blood pressure control and a lower incidence of mild cognitive impairment and dementia than patients receiving usual medical care. Patients will be recruited from UT Southwestern Medical Center and Parkland Health \& Hospital System.
The 2 groups in the trial
- Intervention ArmTreatment being tested
Home BP data will be averaged each month via OmronConnect app on the patients' smartphone, which is programmed to send home BP readings to MyChart via Apple or Google Health.Participants whose home blood pressure reading average is systolic ≥ 130 and diastolic ≥ 80 will trigger the CDS (Clinical Decision Support) tool to assist their physicians with their blood pressure management. Study Team will not be involved in treatment decision making, it will be determined by subject's treating physician. .
Treatment: Clinical Support Decision Tool
- Usual Care ArmNo study treatment, for comparison
Physicians will continue to make decisions about the participant's blood hypertension management as usual without the CDS tool.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Preventing Cognitive Decline by Reducing BP Target Trial
- Plain-language title
- Tests a blood pressure support tool to help protect thinking skillsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 3 December 2025